Enhanced beta cell function after chronic treatment with the dipeptidyl peptidase-4 inhibitor Vildagliptin in an advanced age diet-induced obesity mouse model

被引：0
|
作者：
Omar, B. [1 ]
Vikman, J. [1 ]
Winzell, M. S. [1 ]
Ahren, B. [1 ]
机构：
[1] Lund Univ, S-22100 Lund, Sweden
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
861
引用
收藏
页码：S355 / S356
页数：2
相关论文
共 37 条
  • [1] Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model
    Omar, B. A.
    Vikman, J.
    Winzell, M. S.
    Voss, U.
    Ekblad, E.
    Foley, J. E.
    Ahren, B.
    DIABETOLOGIA, 2013, 56 (08) : 1752 - 1760
  • [2] Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model
    B. A. Omar
    J. Vikman
    M. S. Winzell
    U. Voss
    E. Ekblad
    J. E. Foley
    B. Ahrén
    Diabetologia, 2013, 56 : 1752 - 1760
  • [3] Long-term effect of dipeptidyl peptidase-4 inhibition on β-cell mass in an advanced-aged diet- induced obesity mouse model
    Yamane, Shunsuke
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (02) : 142 - 143
  • [4] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, prevents cardiac hypertrophy and diastolic dysfunction induced by chronic beta-adrenergic stimulation in rat
    Miyoshi, T.
    Nakamura, K.
    Oe, H.
    Yoshida, M.
    Akagi, S.
    Sugiyama, H.
    Miura, D.
    Miura, A.
    Akazawa, K.
    Ito, H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 117 - 117
  • [5] Treatment with the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin Improves Fasting Islet-Cell Function in Subjects with Type 2 Diabetes
    D'Alessio, David A.
    Denney, Amanda M.
    Hermiller, Linda M.
    Prigeon, Ronald L.
    Martin, Julie M.
    Tharp, William G.
    Saylan, Monica Liqueros
    He, YanLing
    Dunning, Beth E.
    Foley, James E.
    Pratley, Richard E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01): : 81 - 88
  • [6] The dipeptidyl peptidase-4 inhibitor vildagliptin improves β-cell function and insulin sensitivity in subjects with impaired fasting glucose
    Utzschneider, Kristina M.
    Tong, Jenny
    Montgomery, Brenda
    Udayasankar, Jayalakshmi
    Gerchman, Fernando
    Marcovina, Santica M.
    Watson, Catherine E.
    Ligueros-Saylan, Monica A.
    Foley, James E.
    Holst, Jens J.
    Deacon, Carolyn F.
    Kahn, Steven E.
    DIABETES CARE, 2008, 31 (01) : 108 - 113
  • [7] The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice
    Fukuda-Tsuru, Sayaka
    Kakimoto, Tetsuhiro
    Utsumi, Hiroyuki
    Kiuchi, Satoko
    Ishii, Shinichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 : 207 - 215
  • [8] The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves insulin sensitivity and β-cell function in subjects with impaired fasting glucose
    Jacobsen, Lisbeth V.
    Hindsberger, Charlotte
    Robson, Richard
    Zdravkovic, Milan
    DIABETES, 2007, 56 : A137 - A137
  • [9] Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
    Toru Miyoshi
    Kazufumi Nakamura
    Masashi Yoshida
    Daiji Miura
    Hiroki Oe
    Satoshi Akagi
    Hiroki Sugiyama
    Kaoru Akazawa
    Tomoko Yonezawa
    Jun Wada
    Hiroshi Ito
    Cardiovascular Diabetology, 13
  • [10] Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
    Miyoshi, Toru
    Nakamura, Kazufumi
    Yoshida, Masashi
    Miura, Daiji
    Oe, Hiroki
    Akagi, Satoshi
    Sugiyama, Hiroki
    Akazawa, Kaoru
    Yonezawa, Tomoko
    Wada, Jun
    Ito, Hiroshi
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
1234